# Growth Hormone and Chromosome 18q- and Abnormal Growth

> **NCT00134420** · PHASE3 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 20 (actual)

## Conditions studied

- Loss of Chromosome 18q
- Growth Hormone Deficiency

## Interventions

- **DRUG:** Nutropin AQ
- **PROCEDURE:** Arginine and Clonidine Stimulation Testing
- **PROCEDURE:** Growth Factors Laboratory Testing
- **PROCEDURE:** Neuropsychological Testing

## Key facts

- **NCT ID:** NCT00134420
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-08-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00134420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00134420, "Growth Hormone and Chromosome 18q- and Abnormal Growth". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00134420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*